NEW YORK (GenomeWeb News) – Shares of Luminex and Sequenom both fell by double digits today following disappointing first-quarter financial reports on Thursday.

In mid-afternoon trade on Friday, shares of Luminex had fallen nearly 13 percent to $15.49 while those of Sequenom had dropped more than 16 percent to $5.08.

Luminex yesterday reported that its second-quarter revenues increased 14 percent to $27.8 million, but this did not meet analyst estimates of $29.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.